Search

Genevieve D Paderes

from San Diego, CA
Age ~72
Get Report
Also known as:
Genevieve G Paderes, Genebiebe D Paderes
Phone and address:
5183 Sea Mist Ct, San Diego, CA 92121
(858) 458-9537
Related to:
Fidel C Paderes, 73
Connected to:
Thomas I Paderes, 40Perfecto D Paderna, 62Rafael N Paderna, 82Esther E Paderni, 73Linda E Padezanin, 63Melanie Padezan, 43Michael A Padezanin, 65April L Padfield, 35Chris D Padfield, 50Harry R Padfield, 97

Genevieve Paderes Phones & Addresses

  • 5183 Sea Mist Ct, San Diego, CA 92121 (858) 458-9537 (619) 458-9537
  • 5340 Toscana Way, San Diego, CA 92122
  • 17161 Alva Rd, San Diego, CA 92127
  • 4 Littles Brook Ct #97, Burlington, MA 01803 (781) 365-1664
  • 59 Cambridge Rd #209, Woburn, MA 01801
  • Spring Valley, NY

Skills

Drug Design • Library Design • Computational Chemistry • Drug Discovery • Data Mining • Virtual Screening • Lead Optimization • Organic Chemistry • Adme • Cheminformatics • Homology Modeling • Molecular Dynamics • Medicinal Chemistry • Molecular Modeling • Spotfire • Docking • Qsar • Lead Change • High Throughput Screening • Protein Chemistry • Structural Biology • Biotechnology • Kinases • Oncology • Clinical Development • Cancer • Gpcrs • Immunology • Parallel Synthesis • Drug Development • Drug Metabolism • Organic Synthesis • Dmpk

Industries

Pharmaceuticals

Resumes

Resumes

Genevieve Paderes Photo 1

Genevieve Paderes

View page
Location:
San Diego, CA
Industry:
Pharmaceuticals
Skills:
Drug Design
Library Design
Computational Chemistry
Drug Discovery
Data Mining
Virtual Screening
Lead Optimization
Organic Chemistry
Adme
Cheminformatics
Homology Modeling
Molecular Dynamics
Medicinal Chemistry
Molecular Modeling
Spotfire
Docking
Qsar
Lead Change
High Throughput Screening
Protein Chemistry
Structural Biology
Biotechnology
Kinases
Oncology
Clinical Development
Cancer
Gpcrs
Immunology
Parallel Synthesis
Drug Development
Drug Metabolism
Organic Synthesis
Dmpk

Publications

Us Patents

Non-Peptide Gnrh Agents, Methods And Intermediates For Their Preparation

View page
US Patent:
20040010033, Jan 15, 2004
Filed:
Jul 8, 2003
Appl. No.:
10/353160
Inventors:
Mark Anderson - Orinda CA, US
Haresh Vazir - Salinas CA, US
David Luthin - Encinitas CA, US
Genevieve Paderes - San Diego CA, US
Ved Pathak - San Diego CA, US
Lance Christie - Vista CA, US
Yufeng Hong - San Diego CA, US
Eileen Tompkins - Escondido CA, US
Haitao Li - San Diego CA, US
James Faust - Temecula CA, US
Assignee:
Pfizer Inc.
International Classification:
A61K031/34
C07D307/02
US Classification:
514/471000, 549/487000
Abstract:
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

Non-Peptide Gnrh Agents, Methods And Intermediates For Their Preparation

View page
US Patent:
7101878, Sep 5, 2006
Filed:
Aug 20, 1999
Appl. No.:
09/763216
Inventors:
Mark Brian Anderson - Orinda CA, US
Haresh N. Vazir - San Diego CA, US
David Robert Luthin - Encinitas CA, US
Genevieve DeGuzman Paderes - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Lance Christopher Christie - Vista CA, US
Yufeng Hong - San Diego CA, US
Eileen Valenzuela Tompkins - Escondido CA, US
Haitao Li - San Diego CA, US
James Faust - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 405/12
C07D 307/68
A61K 31/34
A61K 31/505
A61P 5/04
US Classification:
5142315, 549487, 549488, 514461, 514370, 514336, 514444, 51425505, 514394, 548195, 5483047, 544152, 544405, 546233, 5462847, 546 60
Abstract:
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.
Control profile
Genevieve D Paderes from San Diego, CA, age ~72 Get Report